Every Drug that has been recalled by the FDA… was first proven to be safe and effective by the FDA…

The FDA issued a warning but didn’t ban DES!

Every drug that has been recalled by the FDA... was first proven to be safe and effective by the #FDAFact: In 1947, the FDA approved the use of DES to prevent adverse pregnancy outcomes in women with a history of miscarriage.

Fact: In 1971, The FDA removed prevention of miscarriage as an indication for DES use and added pregnancy as a contraindication for DES use. Yes you read well “contraindication“!

The FDA issued a warning but didn’t ban DES!

On Flickr®

The FDA and Enrofloxacin

FDA Denies Petition to Ban Certain Antibiotics

FDA Denies Petition to Ban Certain Antibiotics

To the dismay of consumer and sustainable agriculture advocates, the Food and Drug Administration rejected two petitions to ban certain antibiotics from being used in food animal production.

In its response to the Center for Science in the Public Interest, the FDA cited the withdrawal of diethylstilbestrol DES in 1979, which took a full seven years to complete, and the withdrawal of enrofloxacin in poultry, which took almost five years and cost FDA approximately $3.3 million. Read more : ” FDA Denies Petition to Ban Certain Antibiotics “.

The lack of transatlantic communication

INSIGHT-In PIP implant Scandal

INSIGHT-In PIP implant scandal, a ragged safety net exposedThe lack of transatlantic communication is just one problem highlighted by the PIP Breast Implant scandal

Really? Nothing new then! … back in 1971 the FDA issued a warning about DES for pregnant women … in France Distilbene continued to be prescribed to pregnant women until 1977! … Now with the PIP scandal, France reacted 10 years after the FDA … !!!! This is just insane and shocking! When will they learn? Read the post ” INSIGHT-In PIP implant scandal, a ragged safety net exposed “.

FDA and Antibiotics

FDA cannot withdraw approval of a new animal drug until the legally-mandated process is complete

FDA Denies Petition to Ban Certain AntibioticsIn its response to CSPI, the FDA cited the withdrawal of Diethylstilbestrol DES in 1979, which took a full seven years to complete, and the withdrawal of enrofloxacin in poultry, which took almost five years and cost FDA approximately $3.3 million.

Read FDA Denies Petition to Ban Certain Antibiotics
BY HELENA BOTTEMILLER | NOVEMBER 10, 2011

The FDA stance regarding Prescription Drug Side-Effects!

See the FDA stance regarding… Prescription Drug Side-Effects! by Dave Granlund … What does FDA stand for? Fatal Drugs Allowed? or does “F” stand for Failure? Looking forward to read your suggestions … via Wellness Uncovered Health Forum http://on.fb.me/PZ3EIP via @des_journal and Diethylstilbestrol, Journal of a DES Daughter

DES DiEthylStilbestrol Resources (6)

Want to know more about the pregnancy drug DiEthylStilbestrol?

DES-molecule image
Five Scary and Shocking Facts about Diethylstilbestrol
Drug companies ignored DES studies results, the FDA did NOT ban the DES drugs, it continued to be used and many new doctors don’t even know about Diethylstilbestrol.

Online Global DES Health History Survey
Calling all DES Mothers, Daughters and Sons!
Did you take part in the new 2012 Diethylstilbestrol health history survey created by DES Action USA and open to all DES-exposed individuals worldwide.

DES Daughters
What is a DES Daughter? Who are they?
Women born between 1938 and 1978, exposed to the anti miscarriage drug Diethylstilbestrol before birth (in the womb) are defined as DES Daughters.

DES Sons
What is a DES Son? Who are they?
Men born between 1938 and 1978, exposed to the anti miscarriage drug Diethylstilbestrol before birth (in the womb) are defined as DES Sons.

1000 Thanks to our 1000 Facebook Fans !
June 21th 2012 marks a Milestone in our efforts to raise awareness of the DES drug scandal and tragedy with 1000 Fans on Facebook.

More DES DiEthylStilbestrol Resources

Diethylstilbestrol Clear Cell Adenocarcinoma Vaginal Cancer

Elevated risk for this type of cancer in DES Daughters as they age

DES and Cancer: the Never Ending Story

Diethylstilbestrol DES clear cell adenocarcinoma CCA vaginal cancer41 years ago, a connection between DES exposure and cancer in DES daughters was established.  Cases of Clear Cell Adenocarcinoma (CCA) of the vagina were diagnosed in an age group never before found to develop it. At the time the peak incidence of CCA in DES Daughters was in the late teens and early 20s. Most young women with CCA of the vagina have a history of prenatal exposure to diethylstilbestrol (DES). DES daughters were told by physicians that the risk was low when you reach your 30s and you can still read today on some websites that “if a DES daughter has not developed this cancer by age 30, she will not develop it”.

But today, DES daughters cancer fears are confirmed and justified as the findings and conclusions of a new report by CDC researchers suggest an elevated risk for this vaginal/cervical cancer in DES Daughters as they age.

When researchers first linked prenatal DES exposure to vaginal / cervical cancer in a small group of women, soon after, the Food and Drug Administration (FDA) notified physicians throughout the U.S.A. that DES should not be prescribed to pregnant women (note that it wasn’t banned!). In Europe, the drug continued to be prescribed to pregnant women until 1978. So even though this report says “elevated risk among women born between 1947 and 1971 in the United States”, it should read “among all women born between 1947 and 1978 in countries where DES was prescribed”. In the United States alone it is estimated that five to 10 million people were exposed to DES between 1938 and 1971.

When will this stop?  The statement “The more I learn the less I know” really seems to apply to the DES tragedy. As we learn more about the devastating health effects of diethylstibestrol, we begin to become more aware of the limits of our knowledge regarding the long term effects not only for DES daughters but also DES sons and the DES 3rd generation (children of DES daughters and sons). DES truly is a never ending story!

Wherever you are stay safe and remind your GP that DES daughters need yearly Pap test and pelvic exam as well as regular health screening and adequate care!

More DES DiEthylStilbestrol Resources

SlideShow DES Adverts

Back in the 1950’s and 1960’s, doctors were the target for most drug advertising campaigns including DES

DES Adverts Information

desPLEX

 

Back in the 1950’s and 1960’s, doctors were the target for most drug advertising campaigns including DES as shows this Flickr album.

Drug companies supplied hundreds of doctors with samples to give to their female patients, thus creating a market for the drug (in the case of diethylstilbestrol even before it was approved by the FDA).

Somehow DES set the template of “How To” market a dangerous drug to women. In 1948, diethylstilbestrol was advertised as the “Wonder Drug” recommended for all pregnancies. The face of a cherubic infant grinned up from the pages of medical journals next to the caption: “Really? Yes, desPLEX to prevent abortion, miscarriage and premature labor…bigger and stronger babies“.

As early as 1953, research revealed that DES did not work – that DES actually brought about higher rates of premature birth and infant mortality – yet DES continued to be prescribed to pregnant women for decades mainly because pharmaceutical companies continued to heavily promote DES use to doctors and most doctors relied on the drug companies and their sales representatives for information.

More DES DiEthylStilbestrol Resources

DES DiEthylStilbestrol Resources (2)

Want to know more about the pregnancy drug DiEthylStilbestrol?

DES-molecule image
My DES Daughter Journey – Introduction
The journey started with a miscarriage and an operation. Now my DES journey is taking a new start with my Diethylstilbestrol “Journal of a DES Daughter”.

My DES Daughter Journey – Doctors
I have been exposed to DES but doctors needed more evidence to accept that diethylstilboestrol had contributed to my miscarriage.

The FDA is lying by omission
M. Henderson (US FDA) and C. McCarthy (screenwriter) communication about the health benefits of limiting the use of DES diethylstilbestrol in pregnancy.

International Women’s Day March 2011
Attend Journal of a DES Daughter International Women’s Day event on Facebook. Celebrate the courage of women affected by diethylstilbestrol.

French study reveals more damaging DES side effects
Link between DES and mental illness issues revealed by a recent study conducted by M.O. Gobillard-Soyer, former director at the CNRS.

More DES DiEthylStilbestrol Resources